Crain’s Detroit Business Profiles ALS Trial
"I know what a placebo effect is. I'm not crazy. This isn't a placebo effect," Ted Harada told one of his doctors last year, practically yelling it at him in a burst of enthusiasm.
Harada, 40, a former manager at FedEx Corp., was one of 15 ALS patients who were part of a recently completed U.S. Food and Drug Administration Phase 1 trial at Emory University in Atlanta -- a trial designed and run in part by researchers at the University of Michigan to inject stem cells into the spine of patients with amyotrophic lateral sclerosis.
Full article - ALS patient: 'This isn't a placebo effect' (PDF)
Stem cell research nears next phase; trials may come to Ann Arbor
Approval by the U.S. Food and Drug Administration is expected any day for researchers and physicians at the University of Michigan to begin a second round of Phase 1 stem cell trials on patients with amyotrophic lateral sclerosis, commonly known as Lou Gehrig's disease.
ALS is a disease of the nerve cells in the brain and spinal cord that control voluntary muscle movement. It usually leads to death within three to five years. Currently, there is no cure.
Full article - Advancing on ALS (PDF)
Dr. Eva Feldman: Alfred Taubman as mentor, leader, friend
The source of his greatness lay in his willingness to challenge conventional thinking.
WDIV covers institute's art + science program
Ch. 4 report profiles the collaboration between Taubman Scholar Tom Gardner and artist Osman Khan.
Taubman Scholars: Reflections on Alfred Taubman
Eminent scientists say his curiosity, interest and vision changed the course of medical science.
news & events
In the News
Taubman Emerging Scholar makes strides against cancer
Erika Newman, M.D., has identified a characteristic of deadly childhood neuroblastoma that may pave the way for more effective treatments.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.